Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells

References

• Akhtar N. Vesicular ocular drug delivery system: preclinical and clinical perspective of drugs delivered via niosomes. Int J Biopharm, 2013;4:38–48.
   Google Scholar
• Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science, 2004;303:1818–22.
   PubMed Web of Science ®Google Scholar
• Allon N, Saxena A, Chambers C, Doctor BP. A new liposome-based gene delivery system targeting lung epithelial cells using endothelin antagonist. J Control Release, 2012;160:217–24.
   PubMed Web of Science ®Google Scholar
• Audouy S, Molema G, De Leij L, Hoekstra D. Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability. J Gene Med, 2000;2:465–76.
   PubMed Web of Science ®Google Scholar
• Bajoria R, Sooranna SR, Contractor SF. Endocytotic uptake of small unilamellar liposomes by human trophoblast cells in culture. Hum Reprod, 1997;12:1343–8.
   PubMed Web of Science ®Google Scholar
• Balazs DA, Godbey W. Liposomes for use in gene delivery. J Drug Deliv, 2011;2011:326497.
   PubMedGoogle Scholar
• Barauskas J, Johnsson M, Tiberg F. Self-assembled lipid superstructures: beyond vesicles and liposomes. Nano Lett, 2005;5:1615–19.
   PubMed Web of Science ®Google Scholar
• Çağdaş M, Sezer AD, Bucak S. 2014. Liposomes as potential drug carrier systems for drug delivery. In: Sezer AD, ed. Application of nanotechnology in drug delivery. Rijeka: InTech.
   Google Scholar
• Calvo P, Remunan-Lopez C, Vila-Jato J, Alonso M. Development of positively charged colloidal drug carriers: chitosan-coated polyester nanocapsules and submicron-emulsions. Colloid Polym Sci, 1997;275:46–53.
   Web of Science ®Google Scholar
• Chang HI, Yeh MK. Clinical development of liposome-based drugs: formulation, characterisation, and therapeutic efficacy. Int J Nanomedicine, 2012;7:49.
   PubMed Web of Science ®Google Scholar
• Chen CW, Yeh MK, Shiau CY, Chiang CH, Lu DW. Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery. Int J Nanomedicine, 2013;8:2613.
   PubMed Web of Science ®Google Scholar
• Colletier JP, Chaize B, Winterhalter M, Fournier D. Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer. BMC Biotechnol, 2002;2:9.
   PubMedGoogle Scholar
• Dan N. Effect of liposome charge and PEG polymer layer thickness on cell-liposome electrostatic interactions. Biochim Biophys Acta, 2002;1564:343–8.
   PubMed Web of Science ®Google Scholar
• Daull P, Buggage R, Lambert G, Faure MO, Serle J, Wang RF, Garrigue JS. A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models. J Ocul Pharmacol Ther, 2012;28:515–23.
   PubMed Web of Science ®Google Scholar
• De La Fuente M, Raviña M, Paolicelli P, Sanchez A, Seijo B, Alonso MJ. Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv drug deliv Rev, 2010;62:100–17.
   PubMed Web of Science ®Google Scholar
• Dinneen JL, Ceresa BP. Expression of dominant negative rab5 in HeLa cells regulates endocytic trafficking distal from the plasma membrane. Exp Cell Res, 2004;294:509–22.
   PubMed Web of Science ®Google Scholar
• Fathalla D, Soliman G, Fouad E. Development and in vitro/in vivo evaluation of liposomal gels for the sustained ocular delivery of latanoprost. J Clin Exp Ophthalmol, 2015;6:2.
   Google Scholar
• Figueiredo S, Cabral R, Luís D, Fernandes AR, Baptista PV. 2014. Conjugation of gold nanoparticles and liposomes for combined vehicles of drug delivery in cancer. In: Seifalian A, ed. Nanomedicine. Manchester: One Central Press, pp. 48–82.
   Google Scholar
• Furrer P, Mayer JM, Gurny R. Ocular tolerance of preservatives and alternatives. Eur J Pharm Biopharm, 2002;53:263–80.
   PubMed Web of Science ®Google Scholar
• Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J, 2010;12:348–60.
   PubMed Web of Science ®Google Scholar
• Hu L, Plafker K, Vorozhko V, Zuna RE, Hanigan MH, Gorbsky GJ, Plafker SM, Angeletti PC, Ceresa BP. Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell–cell fusion. Virology, 2009;384:125–34.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Garg A, Singla AK, Aggarwal D. Vesicular systems in ocular drug delivery: an overview. Int J Pharm, 2004;269:1–14.
   PubMed Web of Science ®Google Scholar
• Kovoor TA, Kim AS, Mcculley JP, Cavanagh HD, Jester JV, Bugde AC, Petroll WM. Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy. Eye Contact Lens, 2004;30:90–4.
   PubMedGoogle Scholar
• Krasnici S, Werner A, Eichhorn ME, Schmitt‐Sody M, Pahernik SA, Sauer B, Schulze B, Teifel M, Michaelis U, Naujoks K. Effect of the surface charge of liposomes on their uptake by angiogenic tumour vessels. Int J Cancer, 2003;105:561–7.
   PubMed Web of Science ®Google Scholar
• Kumar EA, Yuan Z, Palermo NY, Dong L, Ahmad G, Lokesh G, Kolar C, Kizhake S, Borgstahl GE, Band H. Peptide truncation leads to a twist and an unusual increase in affinity for casitas B-lineage lymphoma tyrosine kinase binding domain. J Med Chem, 2012;55:3583–7.
   PubMed Web of Science ®Google Scholar
• Lallemand F, Daull P, Benita S, Buggage R, Garrigue JS. Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb. J Drug Deliv, 2012;2012:604204.
   PubMedGoogle Scholar
• Law S, Huang K, Chiang C. Acyclovir-containing liposomes for potential ocular delivery: corneal penetration and absorption. J Control Release, 2000;63:135–40.
   PubMed Web of Science ®Google Scholar
• Lee KD, Hong K, Papahadjopoulos D. Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. Biochim Biophys Acta, 1992;1103:185–97.
   PubMed Web of Science ®Google Scholar
• Lee KD, Nir S, Papahadjopoulos D. Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes. Biochemistry, 1993;32:889–99.
   PubMed Web of Science ®Google Scholar
• Lutsiak M, Kwon GS, Samuel J. Analysis of peptide and lipopeptide content in liposomes. J Pharm Pharm Sci, 2002;5:279–84.
   PubMedGoogle Scholar
• Mccalden T, Levy M. Retention of topical liposomal formulations on the cornea. Experientia, 1990;46:713–5.
   PubMedGoogle Scholar
• Miller CR, Bondurant B, Mclean SD, Mcgovern KA, O'brien DF. Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilised liposomes. Biochemistry, 1998;37:12875–83.
   PubMed Web of Science ®Google Scholar
• Monem AS, Ali FM, Ismail MW. Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits. Int J Pharm, 2000;198:29–38.
   PubMed Web of Science ®Google Scholar
• Mu FT, Callaghan JM, Steele-Mortimer O, Stenmark H, Parton RG, Campbell PL, Mccluskey J, Yeo JP, Tock EP, Toh BH. EEA1, an early endosome-associated protein. EEA1 is a conserved α-helical peripheral membrane protein flanked by cysteine “fingers” and contains a calmodulin-binding IQ motif. J Biol Chem, 1995;270:13503–11.
   PubMed Web of Science ®Google Scholar
• Navarro G, Essex S, Torchilin VP. 2013. The “non-viral” approach for siRNA delivery in cancer treatment: a special focus on micelles and liposomes. In: Erdmann VA, Barciszewski HJ, eds. RNA Technologies. Berlin: Springer-Verlag, pp. 241–61.
   Google Scholar
• Nie Y, Ji L, Ding H, Xie L, Li L, He B, Wu Y, Gu Z. Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterisation. Theranostics, 2012;2:1092–103.
   PubMed Web of Science ®Google Scholar
• Patel P, Shastri D, Shelat P, Shukla A. Ophthalmic drug delivery system: challenges and approaches. Syst Rev Pharm, 2010;1:113.
   Google Scholar
• Patil SD, Rhodes DG, Burgess DJ. Anionic liposomal delivery system for DNA transfection. AAPS J, 2004;6:13–22.
   Google Scholar
• Pellinen P, Huhtala A, Tolonen A, Lokkila J, Mäenpää J, Uusitalo H. The cytotoxic effects of preserved and preservative-free prostaglandin analogues on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologues in ocular surface tissues in vivo. Curr Eye Res, 2012;37:145–54.
   PubMed Web of Science ®Google Scholar
• Phillips N, Heydari C. Modulation of cationic liposomal DNA zeta potential and liposome‐protein interaction by amphiphilic poly (ethylene glycol). Pharm Pharmacol Commun, 1996;2:73–6.
   Google Scholar
• Pleyer U, Grammer J, Pleyer J, Kosmidis P, Friess D, Schmidt K, Thiel H. [Amphotericin B–bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B]. Ophthalmologe, 1995;92:469–75.
   PubMedGoogle Scholar
• Robertson DM, Li L, Fisher S, Pearce VP, Shay JW, Wright WE, Cavanagh HD, Jester JV. Characterisation of growth and differentiation in a telomerase-immortalised human corneal epithelial cell line. Invest Ophthalmol Visual Sci, 2005;46:470–8.
   PubMed Web of Science ®Google Scholar
• Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Release, 2010;145:182–95.
   PubMed Web of Science ®Google Scholar
• Shankardas J. 2008. Role of 14-3-3sigma in corneal epithelial differentiation. PhD thesis. Fort Worth: University of North Texas Health Science Centre.
   Google Scholar
• Thassu D, Chader GJ. 2012. Ocular drug delivery systems: barriers and application of nanoparticulate systems. Boca Roton: CRC Press.
   Google Scholar
• Torchilin VP. 2003. Liposomes: a practical approach. Oxford: Oxford University Press.
   Google Scholar
• Toropainen E. 2007. Corneal epithelial cell culture model for pharmaceutical studies. PhD thesis. Kuopio: University of Kuopio.
   Google Scholar
• Vivès E, Schmidt J, Pèlegrin A. Cell-penetrating and cell-targeting peptides in drug delivery. Biochim et Biophys Acta, 2008;1786:126–38.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Ueda K, Isowaki A, Ohtori A, Takeuchi H, Ohguro N, Tojo K. Mucoadhesive properties of chitosan-coated ophthalmic lipid emulsion containing indomethacin in tear fluid. Biol Pharm Bull, 2009;32:1266–71.
   PubMed Web of Science ®Google Scholar
• Ye T, Yuan K, Zhang W, Song S, Chen F, Yang X, Wang S, Bi J, Pan W. Prodrugs incorporated into nanotechnology-based drug delivery systems for possible improvement in bioavailability of ocular drugs delivery. Asian J Pharm Sci, 2013;8:207–17.
   Google Scholar
• Yeo Y. 2013. Nanoparticulate drug delivery systems: strategies, technologies, and applications. Hoboken: John Wiley & Sons.
   Google Scholar
• Zhao YZ, Lu CT. Increasing the entrapment of protein-loaded liposomes with a modified freeze-thaw technique: a preliminary experimental study. Drug Dev Ind Pharm, 2009;35:165–71.
   PubMed Web of Science ®Google Scholar
• Zhaorigetu S, Rodriguez-Aguayo C, Sood AK, Lopez-Berestein G, Walton BL. Delivery of negatively charged liposomes into the atherosclerotic plaque of apolipoprotein E-deficient mouse aortic tissue. J liposome Res, 2014;24:182–90.
   PubMed Web of Science ®Google Scholar
• Zhigaltsev IV, Maurer N, Wong KF, Cullis PR. Triggered release of doxorubicin following mixing of cationic and anionic liposomes. Biochim Biophys Acta, 2002;1565:129–35.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Shi S, Han J, Zhang Z, Sun X. Anionic liposomes increase the efficiency of adenovirus-mediated gene transfer to coxsackie-adenovirus receptor deficient cells. Mol Pharm, 2009;7:105–15.
   Web of Science ®Google Scholar